206 related articles for article (PubMed ID: 38879769)
1. Mechanistic Review on the Role of Gut Microbiota in the Pathology of Cardiovascular Diseases.
Usman I; Anwar A; Shukla S; Pathak P
Cardiovasc Hematol Disord Drug Targets; 2024 Jun; ():. PubMed ID: 38879769
[TBL] [Abstract][Full Text] [Related]
2. Update on gut microbiota in cardiovascular diseases.
Qian B; Zhang K; Li Y; Sun K
Front Cell Infect Microbiol; 2022; 12():1059349. PubMed ID: 36439214
[TBL] [Abstract][Full Text] [Related]
3. Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.
Luqman A; Hassan A; Ullah M; Naseem S; Ullah M; Zhang L; Din AU; Ullah K; Ahmad W; Wang G
Front Immunol; 2024; 15():1321395. PubMed ID: 38343539
[TBL] [Abstract][Full Text] [Related]
4. The Role of Gut Microbiota and Associated Compounds in Cardiovascular Health and its Therapeutic Implications.
Liu L; Kaur GI; Kumar A; Kanwal A; Singh SP
Cardiovasc Hematol Agents Med Chem; 2024 Jan; ():. PubMed ID: 38275032
[TBL] [Abstract][Full Text] [Related]
5. The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation.
Rahman MM; Islam F; -Or-Rashid MH; Mamun AA; Rahaman MS; Islam MM; Meem AFK; Sutradhar PR; Mitra S; Mimi AA; Emran TB; Fatimawali ; Idroes R; Tallei TE; Ahmed M; Cavalu S
Front Cell Infect Microbiol; 2022; 12():903570. PubMed ID: 35795187
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota and cardiovascular diseases axis.
Moldovan DC; Ismaiel A; Fagoonee S; Pellicano R; Abenavoli L; Dumitrascu DL
Minerva Med; 2022 Feb; 113(1):189-199. PubMed ID: 33969961
[TBL] [Abstract][Full Text] [Related]
7. The Role of Gut Microbiota in Atherosclerosis and Hypertension.
Ma J; Li H
Front Pharmacol; 2018; 9():1082. PubMed ID: 30319417
[TBL] [Abstract][Full Text] [Related]
8. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases.
Zhen J; Zhou Z; He M; Han HX; Lv EH; Wen PB; Liu X; Wang YT; Cai XC; Tian JQ; Zhang MY; Xiao L; Kang XX
Front Endocrinol (Lausanne); 2023; 14():1085041. PubMed ID: 36824355
[TBL] [Abstract][Full Text] [Related]
9. Interaction between gut microbiome and cardiovascular disease.
Peng J; Xiao X; Hu M; Zhang X
Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota derived metabolites in cardiovascular health and disease.
Wang Z; Zhao Y
Protein Cell; 2018 May; 9(5):416-431. PubMed ID: 29725935
[TBL] [Abstract][Full Text] [Related]
11. Implication of Gut Microbiota in Cardiovascular Diseases.
Zhou W; Cheng Y; Zhu P; Nasser MI; Zhang X; Zhao M
Oxid Med Cell Longev; 2020; 2020():5394096. PubMed ID: 33062141
[TBL] [Abstract][Full Text] [Related]
12. Gut macrobiotic and its metabolic pathways modulate cardiovascular disease.
Zhu J; Lyu J; Zhao R; Liu G; Wang S
Front Microbiol; 2023; 14():1272479. PubMed ID: 37822750
[TBL] [Abstract][Full Text] [Related]
13. Implications of gut microbiome on coronary artery disease.
Xu J; Yang Y
Cardiovasc Diagn Ther; 2020 Aug; 10(4):869-880. PubMed ID: 32968642
[TBL] [Abstract][Full Text] [Related]
14. Diet-gut microbiota interactions on cardiovascular disease.
Zhang X; Gérard P
Comput Struct Biotechnol J; 2022; 20():1528-1540. PubMed ID: 35422966
[TBL] [Abstract][Full Text] [Related]
15. Exploring the Gut Microbiota and Cardiovascular Disease.
Murphy K; O'Donovan AN; Caplice NM; Ross RP; Stanton C
Metabolites; 2021 Jul; 11(8):. PubMed ID: 34436434
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Health and The Intestinal Microbial Ecosystem: The Impact of Cardiovascular Therapies on The Gut Microbiota.
Alhajri N; Khursheed R; Ali MT; Abu Izneid T; Al-Kabbani O; Al-Haidar MB; Al-Hemeiri F; Alhashmi M; Pottoo FH
Microorganisms; 2021 Sep; 9(10):. PubMed ID: 34683334
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota in Hypertension and Atherosclerosis: A Review.
Verhaar BJH; Prodan A; Nieuwdorp M; Muller M
Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003455
[TBL] [Abstract][Full Text] [Related]
18. Intestinal Flora Derived Metabolites Affect the Occurrence and Development of Cardiovascular Disease.
Wen Y; Sun Z; Xie S; Hu Z; Lan Q; Sun Y; Yuan L; Zhai C
J Multidiscip Healthc; 2022; 15():2591-2603. PubMed ID: 36388628
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Diseases of Developmental Origins: Preventive Aspects of Gut Microbiota-Targeted Therapy.
Hsu CN; Hou CY; Hsu WH; Tain YL
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371800
[TBL] [Abstract][Full Text] [Related]
20. The emerging role of gut microbiota in cardiovascular diseases.
Kumar D; Mukherjee SS; Chakraborty R; Roy RR; Pandey A; Patra S; Dey S
Indian Heart J; 2021; 73(3):264-272. PubMed ID: 34154741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
